Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background & Aims: Notwithstanding evidences implicating the lipopolysaccharides (LPS)/toll‐like receptor‐4 (TLR 4) axis in the pathogenesis of NAFLD, there are no studies aimed to characterize hepatic TLR 4 expression in NAFLD patients. We aimed to analyse hepatic TLR 4 expression and to verify its relationship with disease activity/evolution in NAFLD patients. Methods: Liver tissue from 74 patients with NAFLD and 12 controls was analysed by immunohistochemistry (IHC) for TLR 4, α–smooth muscle actin (α–SMA) and cytokeratin‐7. IHC for α–SMA was used to evaluate activation of fibrogenic cells (hepatic stellate cells and portal/septal myofibroblasts), that for cytokeratin‐7 to count hepatic progenitor cells and bile ducts/ductules, and that for CD 68, in a subgroup of 27 patients, for detecting macrophages. Serum LPS‐binding protein (LBP), a sensitive marker of LPS activity, was determined in 36 patients and 32 controls. Results: As confirmed by double‐labelling experiments, the highest level of TLR 4 expression was observed in hepatic progenitor cells, biliary cells and portal/septal macrophages. TLR 4‐positive hepatic progenitor cells and bile ducts/ductules correlated with portal/interface inflammation, activity of fibrogenic cells and fibrosis (P < 0.001). Also the score of TLR 4 positivity of porto‐septal inflammatory infiltrate correlated with number of hepatic progenitor cells and bile ducts/ductules, activity of fibrogenic cells and fibrosis (P < 0.01). Serum LBP was increased in patients compared to controls (P < 0.001), and correlated with portal/interface inflammation, activity of portal/septal myofibroblasts and fibrosis (all P < 0.05). Conclusions: TLR 4 expression by regenerating and inflammatory cells at the porto‐septal and interface level, favoured by increased LPS activity, is associated with activation of fibrogenic cells and the degree of fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907 · cited 2×
“(13): none, perisinusoidal or periportal, perisinusoidal and portal/periportal, bridging fibrosis, cirrhosis.”
BackgroundTLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
White, D. L., Kanwal, F., & El–Serag, H. B. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.001 · Cited by 766 · cited 1×
“acquired that, in some patients, NAFLD is per se a severe disease, with the potential to progress to cirrhosis and hepatocellular carcinoma (21).”
BackgroundBoulter, L., Govaere, O., Bird, T. G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R. A., Seo, S. S., Spee, B., Van Rooijen, N., et al. (2012) · Nature Medicine · doi:10.1038/nm.2667 · Cited by 747 · cited 1×
“It should be underscored that activated portal and periductular macrophages are found in close proximity to hepatic progenitor cells and reactive ductules in animal models and diseased human liver (37, 38), being considered among the cells constituting the ductular reaction, and have been very recently suggested as a…”
BackgroundRivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693 · cited 4×
“Several experimental evidences support TLR4 involvement in the pathogenesis of NAFLD: the steatosic liver is extremely sensitive to LPS-induced damage (2); TLR4 is hyperexpressed in the liver of animals with NASH and altering intestinal microbiota by antibiotics or probiotics protects from NASH (4); pharmacological de…”
BackgroundInfluentialRichardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.012 · Cited by 482 · cited 1×
“It has been suggested that, in the more aggressive forms of NAFLD, the activation of hepatic progenitor cells and the consequent ductular reaction could act as a pacemaker of portal fibrosis (25).”
BackgroundThe portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
Gadd, V. L., Skoien, R., Powell, E. E., Fagan, K. J., Winterford, C., Horsfall, L., Irvine, K., & Clouston, A. D. (2014) · Hepatology · doi:10.1002/hep.26937 · Cited by 452
Clouston, A. D., Powell, E. E., Walsh, M. J., Richardson, M. M., Demetris, A. J., & Jonsson, J. R. (2005) · Hepatology · doi:10.1002/hep.20650 · Cited by 361
Gut Microbiota, Intestinal Permeability, Obesity‐Induced Inflammation, and Liver Injury
Frazier, T. H., DiBaise, J. K., & McClain, C. J. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111413772 · Cited by 306 · cited 2×
“These results are in agreement with the growing literature which suggests that NAFLD patients display changes in microbiota composition, alteration in intestinal tight junctions and gut leakiness and endotoxemia, as recently reviewed (5).”
BackgroundResultMachida, K., Tsukamoto, H., Mkrtchyan, H., Duan, L., Dynnyk, A., Liu, H. M., Asahina, K., Govindarajan, S., Ray, R., Ou, J.-H. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807390106 · Cited by 223
Cited by
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Parthasarathy, G., Revelo, X., & Malhi, H. (2020) · Hepatology Communications · doi:10.1002/hep4.1479 · Cited by 414
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
Carpino, G., Del Ben, M., Pastori, D., Carnevale, R., Baratta, F., Overi, D., Francis, H., Cardinale, V., Onori, P., Safarikia, S., et al. (2020) · Hepatology · doi:10.1002/hep.31056 · Cited by 381
“(15,17) These findings are in keeping with a previous work showing a significant association between portal inflammatory infiltrates and liver fibrosis,(32) and confirms and extends the concept that serum LPS binding protein was significantly associated with portal and interface inflammation.(33) Our data were further…”
Result
Metadata
- Authors
- Vespasiani‐Gentilucci, U., Carotti, S., Perrone, G., Mazzarelli, C., Galati, G., Onetti‐Muda, A., Picardi, A., & Morini, S.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2014-04-05
- Volume
- 35
- Issue
- 2
- Pages
- 569-581
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2098841271
- Cited by
- 99
- References
- 14
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD. https://app.cochat.ai/papers/10.1111/liv.12531
- The paper
- Vespasiani‐Gentilucci, U., Carotti, S., Perrone, G., Mazzarelli, C., Galati, G., Onetti‐Muda, A., Picardi, A., & Morini, S. (2015). Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD. Liver International. https://doi.org/10.1111/liv.12531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.